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Abstract
Background: CRM- based pneumococcal conjugate vaccines generally have little impact on the overall prevalence
of pneumococcal carriage because of serotype replacement. In contrast, protein vaccines could substantially reduce
the overall prevalence of pneumococcal carriage with potential microbiological and clinical consequences. Therefore,
trials of pneumococcal protein vaccines need to evaluate their impact on carriage of other potentially pathogenic
bacteria in addition to the pneumococcus.
Methods: As a prelude to a trial of an investigational pneumococcal vaccine containing pneumococcal
polysaccharide conjugates and pneumococcal proteins, the prevalence of carriage of Streptococcus pneumoniae,
Haemophilus influenzae, Moraxella species and Staphylococcus aureus in the nasopharynx of 1030 Gambian infants
(median age 35 weeks) was determined. An oropharyngeal swab was obtained at the same time from the first 371
infants enrolled. Standard microbiological techniques were used to evaluate the bacterial flora of the pharynx and to
compare that found in the oropharynx and in the nasopharynx.
Results: The overall pneumococcal carriage rate was high. Isolation rates of S. pneumoniae and Moraxella species
were significantly higher using nasopharyngeal rather than oropharyngeal swabs (76.1% [95% CI 73.4%,78.7%] vs.
21.3% [95% CI 17.2%,25.8%] and 48.9% [95% CI 45.8%, 52.0%] vs. 20.5% % [95% CI 16.5%,25.0%] respectively).
In contrast, S. aureus and H. influenzae were isolated more frequently from oropharyngeal than from nasopharyngeal
swabs (65.0% [95% CI 59.9%, 69.8%] vs. 33.6% [95% CI 30.7%, 36.5%] and 31.8% [95% CI 16.5%, 25.0%] vs.
22.4% [95% CI 19.9%, 25.1%] respectively). No group A β haemolytic streptococci were isolated.
Conclusion: Collection of an oropharyngeal swab in addition to a nasopharyngeal swab will provide little additional
information on the impact of a novel pneumococcal vaccine on pneumococcal carriage but it might provide additional,
valuable information on the impact of the vaccine on the overall microbiota of the pharynx.
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Introduction
Pneumonia remains one of the leading causes of mortality in
children < 5 years old [1]. In 2010, it was responsible for 18%
of the approximately 7.6 million deaths in children in this age
group, with approximately 50% of these deaths occurring in
sub-Saharan Africa [2]. Streptococcus pneumoniae (the
pneumococcus) accounts for 30-50% of pneumonia-related
deaths and is a leading cause of death in children < 2 years of
age in developing countries [3]. Other bacterial pathogens that
frequently cause severe acute infections in childhood include
Haemophilus influenzae, Neisseria meningitidis and
Staphylococcus aureus. These pathogens, together with many
commensal bacteria, constitute the bacterial microbiome of the
pharynx [4]. There is increasing interest in the potential for
interaction between the many bacterial species resident in the
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pharynx and in the possibility that interventions targeted at one
species, or against a restricted group within a species, may
influence the overall bacterial flora. For example, at the species
level there is evidence for a negative interaction between S.
aureus and S. pneumoniae in the nasopharynx [5-8] and
competition within species is shown by the phenomenon of
serotype replacement following pneumococcal conjugate
vaccination [9]. For these reasons, consideration needs to be
given to the possibility that introduction of a new vaccine
targeted at one bacterial species resident in the pharynx could
have an impact on the overall bacterial flora of the pharynx,
with potential clinical consequences.
A trial of an investigational pneumococcal vaccine containing
10 pneumococcal polysaccharide non-typeable H. influenzae
conjugates and two pneumococcal proteins proteins (PhtD and
dPly) [10] is being undertaken in Gambian infants
(ClinicalTrials.gov NCT01262872). As a prelude to this trial, a
study was undertaken in the same area where the vaccine trial
is being conducted of the prevalence of pneumococcal carriage
in Gambian infants who had received two or three doses of a
seven-valent pneumococcal conjugate vaccine (PCV-7) as part
of their routine immunisation schedule to determine the
prevalence in infants of carriage with pneumococci of non
vaccine type (NVT) that might be affected by the protein
vaccine. This preliminary study has also provided an
opportunity to determine whether collection of an additional
oropharyngeal (OP) as well as a nasopharyngeal (NP) swab
would help in establishing the impact of this investigational
vaccine on the overall bacterial flora of the pharynx.
Subjects and Methods
Study area and population
The study was conducted in Fajikunda, a peri-urban area
situated on the western margin of The Gambia, approximately
20 km from the capital Banjul. Fajikunda, with a population of
approximately 50,000, is typical of communities on the margins
of large West African cities. The population includes members
from all the main ethnic groups in The Gambia and also
residents from other countries in West Africa. The population is
engaged in a wide range of occupations, including working for
government services, professions and trading. The climate of
the area is typical of the sub-Sahel with a long dry season from
December to July and a shorter rainy season with an average
annual rainfall of around 1200 mm. The study described in this
paper was conducted at the end of the dry season.
Survey methods
Prior to the start of the study, the Fajikunda community was
informed of its purpose and the nature of the investigations to
be performed, starting with community and religious leaders
followed by the general population. The Fajikunda study area
was then mapped and a census taken of all households.
Pregnant women and children under the age of 1 year in each
household were identified and their date of birth and
immunization record were documented. Entry criteria for the
study were an age of 12 months or less and previous
immunisation with two or three doses of a seven-valent
pneumococcal conjugate vaccine (PCV-7) (PrevenarR), with the
last dose having been given at least one month before
sampling (At the time of the study PCV-7 was part of the
Gambian national infant immunisation programme but it has
recently been replaced by a 13-valent vaccine). Households
were sampled systematically across the study area and no
geographical selection, for example of households with a
higher than average social status, was made. Infants who had
received three doses of PCV-7 were recruited first and then
those who had received two doses, with the last dose having
been given at least one month before sampling, in order to
achieve the required sample size.
The study was conducted between April and July 2010. Field
workers trained in the procedure of obtaining OP and NP
swabs visited study subjects in the community. A history of
immunizations, breastfeeding and recent antibiotic use was
obtained. Coverage with three doses of pentavalent vaccine in
the study area was over 90%. Weight was recorded and the
infant’s immunization card examined to obtain the dates on
which each dose of PCV-7 had been administered. A calcium
alginate-tipped swab was then inserted gently through the
nostril into the NP, left to soak for about 5 seconds with gentle
rotation, and removed. An OP specimen was obtained using
the same type of swab passed through the mouth to the
posterior wall of the pharynx. After samples had been obtained,
the tip of each of the ultrafine applicator swabs was cut off and
placed into a tube containing skim milk-tryptone-glucose-
glycerol (STGG) transport media, the tube placed in a cold box
with ice-packs, transported within eight hours to the MRC unit
at Fajara, and then held frozen at -70°C until analysed.
Previous studies conducted in The Gambia [11] and elsewhere
[12] have shown that storage of STGG samples at -70°C for
even prolonged periods does not decrease the viability of
pharyngeal bacteria.
Microbiological methods
Following thawing of the inoculated STGG sample to room
temperature, each tube of NP- or OP-STGG was vortexed
vigorously for a minimum of 20 seconds to homogenise the
bacterial suspension. The suspension was then plated out on
Blood Agar (BA), Gentamicin supplemented blood agar (GBA),
Mannitol salt agar (MSA), Chocolate agar (CA) and Bacitracin
supplemented chocolate agar (BCA) plates for the isolation of
Group A streptococci, S. pneumoniae, S. aureus, Moraxella
species and H. influenzae respectively. All plates were
incubated at 37°C overnight; MSA and BA in O2, GBA, BCA
and CA in 5% CO2.
Characterisation of the five species of bacteria commonly
found in the oropharynx or nasopharynx was carried out based
on their characteristic morphology, Gram stain and biochemical
properties as follows:
S. pneumoniae.  Small, grey, moist/mucoidal colonies
showing alpha-haemolysis on a blood agar plate were selected
for catalase and optochin testing. Catalase negative, optochin
sensitive colonies were serotyped by latex agglutination using
serotype specific antisera (Statens Serum Institute,
Copenhagen, Denmark) as described previously [13].
Confirmation of serotype was made by PCR in an
Bacterial Carriage in Gambian Infants
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approximately 20% of randomly selected samples [14] and
PCR was also used to differentiate between serotypes 6A and
6C.
H. influenzae.  Following overnight incubation, large, round,
colourless to grey opaque colonies were selected from the
BCA plate for oxidase testing and exposure to X+V factors.
Isolates which were oxidase positive and X+V growth factor
dependent were confirmed as H. influenzae. These were
serotyped using BD DifcoTM Hi antisera type a-f (BD, Oxford
Science Park, Oxford, UK).
S. aureus.  Yellowish, slightly raised, colonies on MSA were
sub-cultured onto BA plates to obtain pure colonies. Catalase
and Remel-Staphaurex® (coagulase) (Oxoid & Remel
Products, Thermo, Fisher Scientific, Basingstoke, Hants, UK)
positive isolates were confirmed as S. aureus.
Moraxella species .  Grey-white, dry and brittle colonies
easily lifted with a wire loop were sub-cultured from the CA for
further testing. Oxidase positive, DNase positive, Gram
negative cocci, dipolococci or coccobacilli were confirmed as
Moraxella catarrhalis.
Group A β-haemolytic streptococci.  Colourless, dry, shiny
or mucoid colonies showing beta haemolytic colonies were
selected for catalase and bacitracin testing. Suspected isolates
were typed with Remel Streptex kit (Oxoid & Remel Products,
Thermo, Fisher Scientific, Basingstoke, Hants, UK) to confirm
that they were Group A streptococci (GAS).
The MRC Unit, submits to the external quality assurance
programme of the United Kingdom National External Quality
Assessment Service [15] and is a World Health Organization
(WHO) Regional Reference Laboratory for invasive bacterial
pathogens.
Data entry and analysis
Data forms were double entered, their validity checked and
queries resolved.
The prevalence of S. pneumoniae, S. aureus, H. influenzae,
M. catarrhalis and the Group A β- haemolytic streptococcus in
OP and NP samples was determined. The serotype distribution
of OP and NP isolates of S. pneumoniae was compared. A p-
value for this comparison was obtained by non-parametric
bootstrap to allow for the dependence between samples
(individuals positive for S. pneumoniae on both swabs
contributed data to both samples).
The sensitivity of OP and NP swabs was compared for each
bacterial species in individuals from whom both OP and NP
swabs were taken. Individuals positive on either swab were
considered carriers of the bacterium, i.e. true positives. The
kappa statistic [16] was used to assess the level of agreement
between OP and NP swabs.
Pairwise odds ratios were calculated to quantify the strength
of the association between the bacterial species. The odds
ratios were estimated using the Mantel-Haenszel method to
adjust for age in months, sex and for ethnic group (Madinka,
Jola, Fula, Wollof, Sarahule and others).
Risk factors for carriage of S. pneumoniae in the
nasopharynx were identified using logistic regression. Odds
ratios for the effects of antibiotic use, breastfeeding and
number of PCV doses were adjusted for age, which was
modelled as a fractional polynomial of degree two, ethnicity
and gender.
The study was approved by the Gambia Government/
Medical Research Council Unit Joint Ethics Committee and by
the ethics committee of the London School of Hygiene &
Tropical Medicine. Individual written consent was taken from
the parents or guardians of all study infants before
investigation.
Results
Characteristics of the study population
Nasopharyngeal swabs were collected from 1031 children
from a potentially eligible population of 1487 infants. The
parents of 31 infants declined the invitation to join the study,
the families of 47 infants could not be found at the time of the
survey and the families of 378 were not approached after the
pre-set sample size had been reached. The characteristics of
the infants enrolled in the trial (ethnicity, age, sex, weight,
breastfeeding experience, recent antibiotic use and number of
doses of PCV-7 received) are shown in Table 1. OP swabs
were collected from the first 371 subjects studied (financial
constraints precluded the collection of a larger number of OP
samples). There were no significant differences between the
characteristics of children from whom only an NP swab was
obtained and those from whom both OP and NP swabs were
collected (Table 1).
Nasopharyngeal swabs
S. pneumoniae was the commonest pathogen isolated from
NP swabs (76.1% [95% CI 73.4%, 78.7%] followed by M.
catarrhalis (48.9%) [95% CI 45.8%, 52.0%) (Figure 1). S.
aureus was isolated from 33.6% [95% CI 30.7%, 36.5%] of NP
swabs and H. influenzae from 22.4% [95% CI 19.9%, 25.1%].
No group A β-haemolytic streptococci were isolated from NP
swabs. The prevalence of NP carriage by age for the four study
organisms identified is shown in Figure 2. The prevalence of
carriage of S. pneumoniae, H. influenzae and Moraxella
species increased gradually with age, whilst the prevalence of
carriage with S. aureus showed a trend in the opposite
direction.
The serotype distribution of the pneumococci obtained from
NP swabs is shown in Table 2. The commonest serotype
carried in the NP was 6A. The serotypes covered by PCV-7
constituted 14.5% of the pneumococcal isolates, while 15.3%
and 38.0% belonged to serotypes covered by PCV-10 and
PCV-13 respectively. No serotype 6C isolate was detected.
The prevalence of PCV-7 vaccine serotypes and non-vaccine
serotypes was similar in infants who had received three or two
doses of PCV-7 [11.2% vs. 9.6%; OR = 1.16 (0.62, 2.17) and
65.5% vs. 67.6%, OR = 0.84 (0.57, 1.26) respectively]. One
hundred and sixty-eight H. influenzae isolates could be
reactivated for serotyping; 13 (7.7%) belonged to serotype b, 9
(5.4%) to serotype a, 10 (6.0%) to serotype c, 2 (1.2%) to
serotype d, 4 (2.4%) to serotype e, 3 (1.8%) to serotypes f,
whilst the remaining 127 (75.5%) were untypeable.
Interactions between the different species of bacteria in the
nasopharynx are shown in Table 3. A statistically significant
Bacterial Carriage in Gambian Infants
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positive association was found between the presence of S.
pneumoniae and H. influenzae [OR = 1.86 (1.21, 2.87)]. No
significant association between the presence of S. pneumoniae
and S. aureus was observed [OR= 1.05 (0.74, 1.47)].
Approximately 8% of infants were reported to have received
antibiotics since birth. No significant difference was seen in the
prevalence of carriage of S. pneumoniae, H. influenzae, M.
catarrhalis or S. aureus between the 80 infants whose parents
or guardians reported the administration of antibiotics than in
the 951 infants without a history of recent antibiotic use.
Oropharyngeal swabs
The bacteria isolated from OP swabs are shown in Figure 1.
The commonest pathogen isolated from the OP was S. aureus
(65.0% [95% CI 59.9%, 69.8%]) followed by H. influenzae
(31.8% [95% CI 27.1%, 36.8%]). S. pneumoniae and M.
catarrhalis were isolated from 21.3% [95% CI 17.2%, 25.8%],
20.5% [95% CI 16.5%, 25.0%] of OP swabs respectively. No
serogroup A β-haemolytic streptococci were obtained. The
distribution of potential pathogens in the OP by age is shown in
Figure 2. This was similar to the pattern seen for NP swabs.
Table 1. Characteristics of study population.
  OP+NP N (%) NP only N (%) All N (%)
Ethnicity Mandinka 156 (42) 203 (31) 359 (35)
 Jola 74 (20) 123 (19) 197 (19)
 Fula 55 (15) 118 (18) 173 (17)
 Wollof 48 (13) 101 (15) 149 (14)
 Sarahule 14 (4) 41 (6) 55 (5)
 Other 24 (6) 73 (11) 97 (9)
 Total 371 (100) 659 (100) 1030 (100)
Gender Male 211 (57) 359 (54) 570 (55)
 Female 160 (43) 301 (46) 461 (45)
 Total 371 (100) 660 (100) 1031 (100)
Antibiotic use
since birth No 340 (92) 611 (93) 951 (92)
 Yes 31 (8) 49 (7) 80 (8)
 Total 371 (100) 660 (100) 1031 (100)
Feeding
practice* None 1(0) 4 (1) 5(0)
 Mixed feeding 331 (89) 570 (86) 901 (87)
 Breast milk +water 21 (6) 63 (10) 84 (8)
 Breast milkonly 18 (5) 23 (3) 41 (4)
 Total 371 (100) 660 (100) 1031 (100)
No. doses
PCV 2 35 (9) 101 (15) 136 (13)
 3 336 (91) 559 (85) 895 (87)
 Total 371 (100) 660 (100) 1031 (100)
Age in weeks Median (IQR) 35.3(27.4,46.9) 35.4(27.1,46.6) 35.3(27.4,46.6)
Weight (Kg) Median (IQR) 8.1(7.0,9.0) 7.6(6.7,8.5) 7.7(6.8,8.7)
*. Feeding practice at the time that a swab was collected.
doi: 10.1371/journal.pone.0075558.t001
The pneumococcal serotype distribution in the OP was
generally similar to that of the NP, with serotype 6A (11.4%)
being found most frequently (Table 2). However, the
prevalence of the serotypes covered by the PCVs was
generally higher in the OP than in the NP swabs, being 23.8%,
25.0% and 47.5% for PCV-7, PCV-10 and PCV-13 respectively
in the NP isolates compared to 14.4%, 15.2% and 37.7%
among the OP isolates, with differences for several serotypes
being of borderline statistical significance (Table 2). Seventeen
H. influenzae isolates could be reactivated for serotyping; 1
belonged to serotype b, 1 to serotype c, and 1 to serotype d,
whilst the remaining 14 (82.4%) were untypeable.
A positive association was found between carriage of H.
influenzae and M. catarrhalis [OR = 2.11 (1.12, 3.96)] and
between carriage of H. influenzae and S. aureus [OR= 1.65
(0.95, 2.85)]. No significant association between carriage of S.
pneumoniae and S. aureus was observed.
Comparison of the findings from oral and
nasopharyngeal swabs
Assuming that the detection of a bacterial species in either
the NP or the OP as indicative of pharyngeal colonisation, the
sensitivity of OP and NP swabs at detecting specific species
are shown in Table 4. These estimates are likely to over-
estimate sensitivity since some colonisation will have been
missed by both swabs using conventional microbiological as
opposed to more sensitive molecular techniques.
Nasopharyngeal swabs were significantly more sensitive than
OP swabs at detecting S. pneumoniae and M. catarrhalis whilst
the reverse was the case for S. aureus and H. influenzae. The
kappa statistics gave low values for the comparisons between
OP and NP swabs for all four species studied.
Risk factors for carriage
The prevalence of carriage in the nasopharynx increased
significantly with age from 15 weeks up to 1 year (Table 5), and
was highest amongst Fula and Jola children. Carriage was
reduced among children who had been treated with antibiotics
at some point since birth and among children who had received
three, rather than two, doses of pneumococcal conjugate
vaccine; although neither of these latter two associations was
statistically significant.
Discussion
This study was conducted to determine the carriage rates of
S. pneumoniae, S. aureus, H. influenzae and Moraxella
species in infants who had been vaccinated with PCV-7 prior to
the future conduct of a trial of an investigational pneumococcal
vaccine in a similar group of infants resident in the same area.
The study was undertaken in a representative sample of a peri-
urban area near Banjul, the capital of The Gambia, and its
findings are likely to reflect those that would be found in the
large peri-urban areas of other West African cities where PCVs
have been introduced. A very high pneumococcal carriage rate
(76.1% [95% CI 73.4%, 78.7%]) was found, as recorded in The
Gambia on several previous occasions before the introduction
of PCV-7 regardless of whether the survey was conducted in
Bacterial Carriage in Gambian Infants
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the dry or rainy season [13,17,18,19]. In these earlier studies,
40%-50% of pneumococcal isolates belonged to serotypes
covered by PCV-7. However, following vaccination with PCV-7
or with an experimental 9-valent conjugate vaccine, the
proportion of isolates of PCV-7 serotype fell to around 10%, a
figure similar to that observed in this study (14.5%) [19,20]. The
high prevalence of carriage of pneumococci of non-PCV10 and
PCV-13 vaccine serotypes in the nasopharynx of infants in the
trial community (65% and 47% respectively) will facilitate the
ability of the trial of the investigational pneumococcal vaccine
to determine whether it has any impact on carriage of
serotypes of pneumococci not covered by the PCV-10 or
PCV-13 conjugate vaccines with which it is being compared.
There was little influence of age on carriage of any of the
potential pathogens studied during the first year of life,
although there was a trend towards increasing prevalence with
age of carriage with S. pneumoniae and H. influenzae but a
decrease with age for S. aureus, as noted in a previous
detailed study in Gambian infants which used molecular
diagnostic methods [21].
Isolation rates of four common bacterial colonisers of the
pharynx obtained with either a NP or an OP swab were
compared. Nasopharyngeal swabs were more sensitive at
detecting S. pneumoniae and M. catarrhalis whereas OP
swabs were more sensitive at detecting S. aureus and H.
influenzae. The finding of a higher isolation of pneumococci
from NP than OP swabs is in keeping with previous findings in
children [22-25] and in adults [26,27] in industrialised countries
and with the results of a study undertaken in children in the
Philippines [28]. In Israel, the higher isolation rate of
pneumococci from NP as opposed to OP was more marked in
children and in their mothers [29]. We are unaware of any
previous study that has made this comparison in a situation of
high intensity pneumococcal transmission such as that found in
sub-Saharan Africa. Comparison of isolation rates from NP and
OP of bacterial species other than the pneumococcus have
been few and have given more varied results. In children in the
UK [22], the Philippines [28] and Israel [29] isolation rates of H.
influenzae were not statistically different when NP or OP swabs
were used. However, in children in Finland [24]and adults in
Israel [29] the isolation rate of H. influenzae was higher using
OP rather than NP swabs, as we found in our study. Even
fewer studies have looked at differential colonisation rates by
Moraxella species but, in Israeli adults, these bacteria were
isolated more frequently from NP than from OP swabs [27] as
was the case in our study.
There is increasing interest in interactions between bacterial
species in the nasopharynx because of the possibility of
interrupting this balance through vaccination, with possible
clinical consequences. In our study, a positive association was
found between the presence of S. pneumoniae and H.
influenzae in both the nasopharynx and the oropharynx, as
noted in South African children [6] but the association was
statistically significant only in the nasopharynx. This
Figure 1.  Prevalence (%) of bacterial species obtained from oral or nasopharyngeal swabs.  
doi: 10.1371/journal.pone.0075558.g001
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association may be due to the fact that colonisation with these
two species of common bacteria has common risk factors
related to socio-economic status, nutritional status and
hygiene. We did not find a negative association between S.
pneumoniae and S. aureus, as had been expected as this has
been noted previously in Gambian infants [21] and in studies
elsewhere [5,6,7]. The reason why this negative interaction
was not apparent is not clear; it might have been hidden by the
confounding effect of risk factors common to the two
pathogens, but it is unlikely to have been due to seasonality or
recent changes in antibiotic practice. Absence of an inverse
correlation between the presence of S. pneumoniae and S.
aureus is an encouraging finding as it suggests that if the new
protein vaccine does reduce the overall prevalence of
pneumococcal carriage this may not lead to a concomitant
increase in carriage of S. aureus.
Little is known about the reasons for the differences in
preferential localisation of potential pathogens in the upper
respiratory tract. Preferential selection of sites for colonisation
could reflect the presence of different epithelial cell ligands in
the oropharynx and nasopharynx or it could be a reflection of
differential innate or acquired immune responses at these two
sites. Although OP swabs gave a pneumococcal carriage rate
about three times less than the NP, the proportion of serotypes
Figure 2.  Age distribution by week of age of pathogens by site of isolation.  Circles indicate nasopharyngeal swabs, triangles
oropharyngeal swabs.
doi: 10.1371/journal.pone.0075558.g002
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covered by PCV7 was higher in the OP than in the NP isolates.
This could have been a chance finding but it could also indicate
Table 2. Prevalence of vaccine serotypes among swabs
positive for S. pneumoniae.
 
Oropharyngeal % (95% CI)
(N=79)
Nasopharyngeal % (95% CI)
(N=785) P-value
1 0.0(0.0,4.6) 0.0(0.0,0.5) NA
3 8.9(3.6,17.4) 2.5(1.6,3.9) 0.052
4 0.0(0.0,4.6) 0.4(0.1,1.1) NA
5 1.3(0.0,6.9) 0.5(0.1,1.3) 0.539
6A 11.4(5.3,20.5) 14.6(12.2,17.3) 0.367
6B 5.1(1.4,12.5) 0.9(0.4,1.8) 0.096
7F 0.0(0.0,4.6) 0.3(0.0,0.9) NA
9V 0.0(0.0,4.6) 0.0(0.0,0.5) NA
14 7.5(2.8,15.6) 4.7(3.3,6.4) 0.349
18C 0.0(0.0,4.6) 0.3(0.0,0.9) NA
19A 5.1(1.4,12.5) 5.6(4.1,7.5) 0.831
19F 6.3(2.1,14.2) 6.0(4.4,7.9) 0.899
23F 5.1(1.4,12.5) 2.2(1.3,3.4) 0.215
PCV71 23.8(14.9,34.6) 14.4(12.0,17.0) 0.048
PCV102 25.0(16.0,35.9) 15.2(12.7,17.9) 0.052
PCV133 47.5(36.2,59.0) 37.7(34.3,41.2) 0.084
NA = Not Applicable
1. PCV7 serotypes include serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F plus 6A
which shows cross- protective immunity with serotype 6B.
2. PCV10 serotypes include the above plus serotypes 1, 5, 7F
3. PCV-13 serotypes include the PCV7 serotypes plus 1, 3, 5, 6A, 7F, 19A
doi: 10.1371/journal.pone.0075558.t002
Table 3. Odds ratios with 95% confidence intervals
(adjusted for age, sex and ethnicity) for the associations
between bacterial species found in the oropharynx or
nasopharynx.
Nasopharynx     
 S.pneumoniae S. aureus H. influenza M. catarrhalis
S.
pneumoniae 1 1.05(0.74,1.47) 1.86(1.21,2.87) 1.15(0.83,1.60)
S. aureus  1 1.39(0.99,1.95) 1.22(0.92,1.62)
H. influenzae   1 1.36(0.99,1.87)
M. catarrhalis    1
Oropharynx     
 S.pneumoniae S. aureus H. influenza M. catarrhalis
S.
pneumoniae 1 0.82(0.46,1.46) 1.29(0.71,2.33) 1.25(0.62,2.52)
S. aureus  1 1.65(0.95,2.85) 1.46(0.80,2.69)
H. influenzae   1 2.11(1.12,3.96)
M. catarrhalis    1
doi: 10.1371/journal.pone.0075558.t003
that the induction of local immunity to carriage by PCV-7 is
stronger in the NP than in the OP.
A weakness of this study is that, for financial reasons, it was
only possible to compare results obtained by OP or NP swabs
in a sub-sample of study infants. However, the fact that infants
in the OP + NP and NP alone groups were well matched for
characteristics that may have influenced carriage rates and the
high overall rate of carriage of the various bacteria studied
makes the findings of this comparative study robust.
The findings of this study indicate little additional information
will be gained by collecting an OP swab in addition to a NP
swab if the sole focus of an intervention is to evaluate its
Table 4. Sensitivity of oral and nasopharyngeal swabs for
detecting four bacterial species in the pharynx.
 N†
Oropharyngeal %
(95% CI)
Nasopharyngeal %
(95% CI) Kappa (95% CI)
S. pneumoniae 278 28.4(23.2,34.1) 95.7(92.6,97.7) 0.09(0.03,0.15)
S. aureus 266 90.6(86.4,93.8) 32.0(26.4,37.9) 0.04(-0.03,0.11)
H. influenzae 170 69.4(61.9,76.2) 46.5(38.8,54.3) 0.03(-0.07,0.12)
M. catarrhalis 214 35.5(29.1,42.3) 81.8(75.9,86.7) 0.01(-0.07,0.10)
Kappa represents the level of agreement.
† Number of individuals carrying the bacteria on at least one of the swabs. Oral
and nasopharyngeal swabs were obtained from 371 individuals.
doi: 10.1371/journal.pone.0075558.t004
Table 5. Risk factors for carriage of S. pneumoniae in the
nasopharynx.
  N Carriage %OR† Pvalue
Age (weeks) 15-24 181 69.6 1  
 25-34 321 76.0 1.38(0.92,2.08)  
 35-44 240 82.1 2.00(1.27,3.16)  
 45-53 181 79.6 1.70(1.05,2.75) 0.020
Ethnicity Mandinka 359 70.8 1  
 Jola 197 83.2 2.05(1.33,3.18)  
 Fula 173 83.8 2.14(1.35,3.41)  
 Wollof 149 77.2 1.40(0.90,2.18)  
 Sarahule 55 67.3 0.85(0.46,1.56)  
 Other 97 72.2 1.07(0.65,1.77) 0.001
Gender Male 570 75.8 1  
 Female 461 76.6 1.04(0.78,1.39) 0.769
Antibiotic use since
birth No 951 76.7 1  
 Yes 80 70.0 0.72(0.43,1.20) 0.210
Breastfeeding None or mixed 906 76.0 1.00  
 Exclusive orwith water 125 76.8 1.24(0.77,2.00) 0.384
PCV No. doses 2 136 76.5 1  
 3 895 76.1 0.89(0.57,1.39) 0.620
† Odds ratios are unadjusted except for antibiotic use, breastfeeding and number
of PCV doses which are adjusted for age, ethnicity and gender. Age adjusted for
using fractional polynomials of degree 2.
doi: 10.1371/journal.pone.0075558.t005
Bacterial Carriage in Gambian Infants
PLOS ONE | www.plosone.org 7 September 2013 | Volume 8 | Issue 9 | e75558
impact on carriage of pneumococci. If, however, there is
concern that an intervention may have a more general effect on
the overall bacterial flora of the pharynx then both OP and NP
swabs may be needed.
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